These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28401485)

  • 41. Silibinin Triggers the Mitochondrial Pathway of Apoptosis in Human Oral Squamous Carcinoma Cells.
    Murali Iyangar R; Devaraj E
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):1877-1882. PubMed ID: 32711410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells.
    Cho HJ; Suh DS; Moon SH; Song YJ; Yoon MS; Park DY; Choi KU; Kim YK; Kim KH
    J Agric Food Chem; 2013 May; 61(17):4089-96. PubMed ID: 23570653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells.
    Zhang Y; Ge Y; Chen Y; Li Q; Chen J; Dong Y; Shi W
    Cell Biochem Funct; 2012 Apr; 30(3):243-8. PubMed ID: 22170400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
    Shukla SK; Dasgupta A; Mehla K; Gunda V; Vernucci E; Souchek J; Goode G; King R; Mishra A; Rai I; Nagarajan S; Chaika NV; Yu F; Singh PK
    Oncotarget; 2015 Dec; 6(38):41146-61. PubMed ID: 26510913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.
    Chen PN; Hsieh YS; Chiou HL; Chu SC
    Chem Biol Interact; 2005 Oct; 156(2-3):141-50. PubMed ID: 16169542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
    Gu HR; Park SC; Choi SJ; Lee JC; Kim YC; Han CJ; Kim J; Yang KY; Kim YJ; Noh GY; No SH; Jeong JH
    Clin Mol Hepatol; 2015 Mar; 21(1):49-59. PubMed ID: 25834802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apicidin inhibits cell growth by downregulating IGF-1R in salivary mucoepidermoid carcinoma cells.
    Ahn MY; Ahn JW; Kim HS; Lee J; Yoon JH
    Oncol Rep; 2015 Apr; 33(4):1899-907. PubMed ID: 25647264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
    Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
    Cancer Res; 2004 Sep; 64(17):6349-56. PubMed ID: 15342425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells.
    Ham J; Lim W; Bazer FW; Song G
    J Cell Physiol; 2018 Feb; 233(2):1638-1649. PubMed ID: 28657208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation.
    Momeny M; Khorramizadeh MR; Ghaffari SH; Yousefi M; Yekaninejad MS; Esmaeili R; Jahanshiri Z; Nooridaloii MR
    Eur J Pharmacol; 2008 Sep; 591(1-3):13-20. PubMed ID: 18599034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death.
    Dhanalakshmi S; Agarwal P; Glode LM; Agarwal R
    Int J Cancer; 2003 Sep; 106(5):699-705. PubMed ID: 12866029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway.
    Tiwari P; Kumar A; Balakrishnan S; Kushwaha HS; Mishra KP
    Cancer Invest; 2011 Jan; 29(1):12-20. PubMed ID: 21166494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
    Fan S; Qi M; Yu Y; Li L; Yao G; Tashiro S; Onodera S; Ikejima T
    Free Radic Res; 2012 Mar; 46(3):310-9. PubMed ID: 22283740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Silymarin amplifies apoptosis in ectopic endometrial tissue in rats with endometriosis; implication on growth factor GDNF, ERK1/2 and Bcl-6b expression.
    Nahari E; Razi M
    Acta Histochem; 2018 Nov; 120(8):757-767. PubMed ID: 30195499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
    Ahmad N; Gali H; Javed S; Agarwal R
    Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silibinin induced-autophagic and apoptotic death is associated with an increase in reactive oxygen and nitrogen species in HeLa cells.
    Fan S; Li L; Chen S; Yu Y; Qi M; Tashiro S; Onodera S; Ikejima T
    Free Radic Res; 2011 Nov; 45(11-12):1307-24. PubMed ID: 21875385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silymarin augments human cervical cancer HeLa cell apoptosis via P38/JNK MAPK pathways in serum-free medium.
    Huang Q; Wu LJ; Tashiro S; Onodera S; Li LH; Ikejima T
    J Asian Nat Prod Res; 2005 Oct; 7(5):701-9. PubMed ID: 16176902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin.
    Bhatia N; Zhao J; Wolf DM; Agarwal R
    Cancer Lett; 1999 Dec; 147(1-2):77-84. PubMed ID: 10660092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silibinin protects murine fibroblast L929 cells from UVB-induced apoptosis through the simultaneous inhibition of ATM-p53 pathway and autophagy.
    Liu W; Otkur W; Zhang Y; Li Q; Ye Y; Zang L; He H; Hayashi T; Tashiro S; Onodera S; Ikejima T
    FEBS J; 2013 Sep; 280(18):4572-84. PubMed ID: 23829351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silibinin inhibits renal cell carcinoma via mechanisms that are independent of insulin-like growth factor-binding protein 3.
    Cheung CW; Vesey DA; Nicol DL; Johnson DW
    BJU Int; 2007 Feb; 99(2):454-60. PubMed ID: 17313429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.